{
    "clinical_study": {
        "@rank": "107771", 
        "arm_group": [
            {
                "arm_group_label": "IV Ibuprofen 800 mg", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "IV Saline", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "STUDY OBJECTIVES:\n\n        1. To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in\n           decreasing pain in orthopedic trauma patients with fractures of the extremities, face,\n           pelvis and/or ribs compared to patients not receiving the medication.\n\n        2. To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in\n           decreasing the use of opioid analgesics among orthopedic trauma patients with fractures\n           of the extremities, face, pelvis, and/or ribs compared to compared to patients not\n           receiving the medication."
        }, 
        "brief_title": "Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Trauma patient admitted to Trauma ICU or Trauma Step-Down Units.\n\n          2. Fracture of ribs, face, extremities and/or pelvis\n\n          3. Age between 18 and 75 years old\n\n          4. Adequate IV access\n\n          5. Able to self report and communicate pain severity\n\n        Exclusion Criteria:\n\n          1. History of allergy or hypersensitivity to any component of IV Ibuprofen, aspirin (or\n             aspirin related products) NSAIDs, or COX-2 inhibitors\n\n          2. Any intracranial or spinal cord trauma\n\n          3. History of clinically significant bleeding disorders including ITP, DIC or platelet\n             dysfunction\n\n          4. Recent history of intracranial surgery or stroke (within past 30 days)\n\n          5. History of ulcers, gastritis or previous GI bleeding\n\n          6. Renal Impairment (Creatinine > 3.0 mg/dL)\n\n          7. Pregnant or breastfeeding\n\n          8. Otherwise unsuitable in the opinion of the treating physician at time of\n             randomization."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "134", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02152163", 
            "org_study_id": "WIRB Protocol #20121749"
        }, 
        "intervention": {
            "arm_group_label": "IV Ibuprofen 800 mg", 
            "intervention_name": "IV Ibuprofen", 
            "intervention_type": "Drug", 
            "other_name": "IV Caldolor"
        }, 
        "intervention_browse": {
            "mesh_term": "Ibuprofen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients", 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "last_name": "Russell Weisz, MD", 
                "phone": "561-496-6622"
            }, 
            "facility": {
                "address": {
                    "city": "Delray Beach", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33484"
                }, 
                "name": "Delray Medical Center"
            }, 
            "investigator": {
                "last_name": "Russell Weisz, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients", 
        "overall_contact": {
            "last_name": "Russell Weisz, MD", 
            "phone": "561-496-6622"
        }, 
        "overall_official": {
            "affiliation": "Delray Medical Center", 
            "last_name": "Russell Weisz, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain will be measured using either a Visual Anolog Scale or a Numeric Rating Scales. A baseline pain score will be obtained prior to adminstration either placebo or IV ibuprofen. Pain assessements will be obtained from both groups 4hrs/2days and then twice daily for a total of 5days.", 
            "measure": "Efficacy of IV Ibuprofen in orthropedic trauma patients", 
            "safety_issue": "No", 
            "time_frame": "Pain Scale End of Day 5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02152163"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Delray Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Delray Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}